[ad_1]
Moderna inventory plummeted Thursday after the corporate reported earnings of $2.53 per share on $3.36 billion in third-quarter gross sales.
X
On common, analysts polled by FactSet anticipated Moderna (MRNA) to earn $3.30 per share on $3.53 billion in gross sales.
Within the year-earlier interval, Moderna earnings had been $7.70 a share and the Covid vaccine maker reported $4.97 billion in gross sales.
Moderna lower its outlook for the 12 months and now expects $18 billion to $19 billion in income tied to present buy agreements. The corporate famous provide points have delayed a few of its deliveries. Moderna inventory analysts known as for earnings of $25.57 a share and $21.3 billion in gross sales.
In premarket buying and selling on at this time’s inventory market, Moderna inventory tumbled 11.7% close to 131.30.
Extra to observe.
Observe Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE:
How Novo Nordisk Is Making an attempt To Lengthen Its Lead In Weight Loss Over Eli Lilly
GSK Surges As Shingles Vaccine Drives Commanding Third-Quarter Beat
Shares To Purchase And Watch: High IPOs, Huge And Small Caps, Development Shares
Watch IBD’s Investing Methods Present For Actionable Market Insights
Discover Profitable Shares With MarketSmith Sample Recognition & Customized Screens
[ad_2]
Source link
